Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACAD | AZN | AMGN | GILD | VRTX |
| Company | Acadia Pharmaceutica | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 29.00 | 160.59 | 408.46 | 131.61 | 539.50 |
| High | 29.65 | 162.72 | 417.36 | 134.32 | 546.17 |
| Low | 29.00 | 160.25 | 406.42 | 131.61 | 519.82 |
| Last | 29.39 | 161.91 | 417.20 | 133.06 | 523.91 |
| Change | +0.18 | +0.49 | +6.26 | -0.15 | +27.84 |
| Percent Change | +0.62% | +0.30% | +1.52% | -0.11% | +5.61% |
| Volume | 2,726,400 | 3,745,900 | 1,959,700 | 6,833,700 | 2,682,300 |
| 20-Day Average Volume | 1,751,175 | 3,909,335 | 2,709,270 | 6,990,460 | 1,394,160 |
| Previous | 29.21 | 161.42 | 410.95 | 133.21 | 496.07 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 26.33 | 166.40 | 381.75 | 132.03 | 483.02 |
| 20-Day Raw Stochastic | 95.20% | 39.30% | 98.14% | 41.92% | 72.58% |
| 20-Day Relative Strength | 71.17 | 40.76 | 71.06 | 52.46 | 66.16 |
| Weighted Alpha | +28.49 | -6.33 | +45.75 | +10.34 | +35.46 |
| Today's Opinion | 88% Buy | 100% Sell | 100% Buy | 8% Buy | 100% Buy |
| Yesterday's Opinion | 88% Buy | 100% Sell | 100% Buy | 8% Buy | 100% Buy |
| Last Month's Opinion | 56% Buy | 88% Sell | 72% Buy | 56% Sell | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +14.76% since 08/03/26 | +2.49% since 08/03/26 | +10.12% since 08/03/26 | +1.46% since 08/03/26 | +11.30% since 08/03/26 |
| Low | 25.55 on 08/04/26 | 155.32 on 08/04/26 | 376.02 on 08/04/26 | 129.02 on 08/06/26 | 465.51 on 08/04/26 |
| High | 29.65 on 08/10/26 | 164.45 on 08/05/26 | 418.40 on 08/06/26 | 137.80 on 08/05/26 | 546.17 on 08/10/26 |
| 1-Month | |||||
| %Chg | +12.09% since 07/10/26 | -5.65% since 07/10/26 | +14.81% since 07/10/26 | +2.49% since 07/10/26 | +7.94% since 07/10/26 |
| Low | 24.23 on 07/23/26 | 153.41 on 08/03/26 | 353.95 on 07/15/26 | 127.61 on 07/23/26 | 465.00 on 07/23/26 |
| High | 29.65 on 08/10/26 | 175.04 on 07/29/26 | 418.40 on 08/06/26 | 140.61 on 07/17/26 | 546.17 on 08/10/26 |
| 3-Month | |||||
| %Chg | +31.21% since 05/08/26 | -11.45% since 05/08/26 | +25.78% since 05/08/26 | +1.32% since 05/08/26 | +21.89% since 05/08/26 |
| Low | 20.30 on 05/19/26 | 153.41 on 08/03/26 | 320.96 on 05/19/26 | 121.39 on 06/10/26 | 420.01 on 06/03/26 |
| High | 29.65 on 08/10/26 | 196.41 on 07/02/26 | 418.40 on 08/06/26 | 140.61 on 07/17/26 | 546.17 on 08/10/26 |
| 6-Month | |||||
| %Chg | +29.47% since 02/10/26 | -16.28% since 02/10/26 | +14.41% since 02/10/26 | -9.62% since 02/10/26 | +13.04% since 02/10/26 |
| Low | 19.89 on 03/19/26 | 153.41 on 08/03/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 |
| High | 29.65 on 08/10/26 | 212.71 on 02/18/26 | 418.40 on 08/06/26 | 157.29 on 02/11/26 | 546.17 on 08/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,064,073 | 251,107,520 | 225,551,680 | 164,988,400 | 132,970,968 |
| Shares Outstanding, K | 172,306 | 1,550,908 | 540,632 | 1,239,955 | 253,805 |
| Annual Sales, $M | 1,071,510,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income, $M | 391,000,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Qtr Sales, $M | 307,960,000 | 15,384,000,000 | 10,054,000,000 | 7,803,000,000 | 3,333,900,000 |
| Last Qtr Income, $M | 31,500,000 | 2,507,000,000 | 2,375,000,000 | -10,496,000,000 | 1,099,800,000 |
| 60-Month Beta | 0.81 | 0.26 | 0.41 | 0.32 | 0.30 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.18 on 08/04/26 | 2.63 on 07/27/26 | 6.29 on 08/04/26 | -6.75 on 08/04/26 | 4.73 on 08/03/26 |
| Latest Earnings Date | 11/04/26 | 11/05/26 | 11/03/26 | 10/29/26 | 11/02/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | N/A |
| Next Ex-Dividend Date | N/A | 02/20/26 | 08/21/26 | 09/15/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 47.11 | 16.62 | 18.37 | 0.00 | 29.15 |